Ali R Djalilian, MD
University of Illinois at Chicago
Emerging Leaders
#5025 pts
Current Leaders
#2,5599 pts
All-Time Leaders
#53625 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2021. 4 trials as lead/chair. How it works →
Trials led — by scientific impact
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells for Promoting Corneal Repair
Phase 1CompletedUniversity of Illinois at Chicago
9
impact
Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair
Phase 2RecruitingUniversity of Illinois at Chicago
9
impact
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Early Ph 1CompletedUniversity of Illinois at Chicago
8
impact
Phase II Study of the Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Phase 2RecruitingUniversity of Illinois at Chicago
0
impact